Article Text
Statistics from Altmetric.com
We read with interest the recent paper published on the management of patients awaiting liver transplant.1 The authors carried out a comprehensive review of liver complications, including spontaneous bacterial peritonitis (SBP). They stated that intravenous albumin (IV-A) at a dose of 1.5 g/kg at diagnosis and 1 g/kg 48 h later has been shown to prevent renal impairment and reduces mortality. We would like to address this point as this benefit has only been demonstrated in one clinical trial in which an arbitrary dose of albumin was used.2 …
Footnotes
Funding Fundo de Incentivo à Pesquisa e Eventos do Hospital de Clínicas de Porto Alegre (FIPE/HCPA).
Competing interests None.
Ethics approval This study was approved by Research Ethics Committee of Hospital de Clínicas de Porto Alegre and by the National Committee for Ethics in Research (Ministry of Health, Brazil).
Provenance and peer review Commissioned; internally peer reviewed.